Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,otherAssets,cash,totalCurrentLiabilities,totalCurrentAssets,treasuryStock,otherStockholderEquity,changeToLiabilities,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,currency,esgPopulated,tradeable,market,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,marketState,shortName,exchange,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingPE,epsTrailingTwelveMonths,exchangeDataDelayedBy,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,priceHint,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,fax,industry,address2
t0,IVRO,508057.0,0,,,15203,,15203,,12893,12893,12893,,,,,,0,213386,200493,200493,2310,,15203,15203,74371.0,508057.0,74371.0,582428.0,508057.0,201949.0,47814.0,332665.0,74371.0,534614.0,,,0,460243.0,en-US,US,EQUITY,False,Delayed Quote,-22.301529,0.1241 - 0.1241,0.15972,0.0,0.0,0,0,finmb_327867,Other OTC,InVitro International,USD,8748,4725,0.0619,0.9951769,0.0622 - 0.1994,-0.07529999,-0.3776329,0.0622,0.1994,USD,False,False,us_market,0.1241,1630519605,-0.035620004,0.1241,0.1241,0.1241,1000,PRE,INVITRO INTERNATIONAL,PNK,1564570740,1596034740,1596470400,31.024998,0.004,0,0.03,0.12516694,-0.001066938,-0.008524121,0.118595496,0.005504504,0.046414107,754379,4.136667,15,America/New_York,EDT,-14400000,4,-0.62,,,0.1994,0.0622,0.1252,0.1186,8.75k,4.72k,,,,0.00%,0.00%,,,,,,,,,,,0.00%,,,,,"Sep 29, 2008","Sep 29, 2008",9.35%,8.07%,6.47%,13.73%,696.56k,0.04,-12.90%,56.2k,,65.15k,0.0040,48.80%,332.67k,0.02,,,7.19,0.03,,,Value,92870,Healthcare,"InVitro International develops test kits for non-animal testing in the United States and internationally. Its products include Irritection Assay System, an invitro test, which could be used to detect, rank, and predict the ocular and/or dermal irritation potential of cosmetics, consumer products, pharmaceuticals, and chemical raw materials; and Corrositex, an invitro test that determines chemical corrosivity. The company also provides customized technology services for Irritection Assay System installation and testing process, as well as independent testing laboratory services for irritancy and corrosivity testing requirements. Its products are principally used by the manufacturers of surfactants, petrochemicals, cosmetics, textiles, paper and pulp, pharmaceuticals, films and resins, solvents and cleaners, and other chemical raw materials. The company was founded in 1985 and is headquartered in Placentia, California.",Placentia,949-851-8356,CA,851990400,United States,http://www.invitrointl.com,86400,330 East Orangethorpe Avenue,949-851-4985,Diagnostics & Research,Suite D
t-1,IVRO,440628.0,0,,,10220,,10220,,8282,8282,8282,,,,,,0,244979,236697,236697,1938,,10220,10220,62245.0,440628.0,62245.0,502873.0,440628.0,178636.0,53369.0,270868.0,62245.0,449504.0,,,0,387259.0,en-US,US,EQUITY,False,Delayed Quote,-22.301529,0.1241 - 0.1241,0.15972,0.0,0.0,0,0,finmb_327867,Other OTC,InVitro International,USD,8748,4725,0.0619,0.9951769,0.0622 - 0.1994,-0.07529999,-0.3776329,0.0622,0.1994,USD,False,False,us_market,0.1241,1630519605,-0.035620004,0.1241,0.1241,0.1241,1000,PRE,INVITRO INTERNATIONAL,PNK,1564570740,1596034740,1596470400,31.024998,0.004,0,0.03,0.12516694,-0.001066938,-0.008524121,0.118595496,0.005504504,0.046414107,754379,4.136667,15,America/New_York,EDT,-14400000,4,-0.62,,,0.1994,0.0622,0.1252,0.1186,8.75k,4.72k,,,,0.00%,0.00%,,,,,,,,,,,0.00%,,,,,"Sep 29, 2008","Sep 29, 2008",9.35%,8.07%,6.47%,13.73%,696.56k,0.04,-12.90%,56.2k,,65.15k,0.0040,48.80%,332.67k,0.02,,,7.19,0.03,,,Value,92870,Healthcare,"InVitro International develops test kits for non-animal testing in the United States and internationally. Its products include Irritection Assay System, an invitro test, which could be used to detect, rank, and predict the ocular and/or dermal irritation potential of cosmetics, consumer products, pharmaceuticals, and chemical raw materials; and Corrositex, an invitro test that determines chemical corrosivity. The company also provides customized technology services for Irritection Assay System installation and testing process, as well as independent testing laboratory services for irritancy and corrosivity testing requirements. Its products are principally used by the manufacturers of surfactants, petrochemicals, cosmetics, textiles, paper and pulp, pharmaceuticals, films and resins, solvents and cleaners, and other chemical raw materials. The company was founded in 1985 and is headquartered in Placentia, California.",Placentia,949-851-8356,CA,851990400,United States,http://www.invitrointl.com,86400,330 East Orangethorpe Avenue,949-851-4985,Diagnostics & Research,Suite D
t-2,IVRO,489038.0,0,,,11801,,11801,,16207,16207,16207,,,,,,0,169806,153599,153599,-4406,,11801,11801,34930.0,489038.0,34930.0,523968.0,,217126.0,202249.0,104593.0,34930.0,321719.0,489038.0,489038.0,0,286789.0,en-US,US,EQUITY,False,Delayed Quote,-22.301529,0.1241 - 0.1241,0.15972,0.0,0.0,0,0,finmb_327867,Other OTC,InVitro International,USD,8748,4725,0.0619,0.9951769,0.0622 - 0.1994,-0.07529999,-0.3776329,0.0622,0.1994,USD,False,False,us_market,0.1241,1630519605,-0.035620004,0.1241,0.1241,0.1241,1000,PRE,INVITRO INTERNATIONAL,PNK,1564570740,1596034740,1596470400,31.024998,0.004,0,0.03,0.12516694,-0.001066938,-0.008524121,0.118595496,0.005504504,0.046414107,754379,4.136667,15,America/New_York,EDT,-14400000,4,-0.62,,,0.1994,0.0622,0.1252,0.1186,8.75k,4.72k,,,,0.00%,0.00%,,,,,,,,,,,0.00%,,,,,"Sep 29, 2008","Sep 29, 2008",9.35%,8.07%,6.47%,13.73%,696.56k,0.04,-12.90%,56.2k,,65.15k,0.0040,48.80%,332.67k,0.02,,,7.19,0.03,,,Value,92870,Healthcare,"InVitro International develops test kits for non-animal testing in the United States and internationally. Its products include Irritection Assay System, an invitro test, which could be used to detect, rank, and predict the ocular and/or dermal irritation potential of cosmetics, consumer products, pharmaceuticals, and chemical raw materials; and Corrositex, an invitro test that determines chemical corrosivity. The company also provides customized technology services for Irritection Assay System installation and testing process, as well as independent testing laboratory services for irritancy and corrosivity testing requirements. Its products are principally used by the manufacturers of surfactants, petrochemicals, cosmetics, textiles, paper and pulp, pharmaceuticals, films and resins, solvents and cleaners, and other chemical raw materials. The company was founded in 1985 and is headquartered in Placentia, California.",Placentia,949-851-8356,CA,851990400,United States,http://www.invitrointl.com,86400,330 East Orangethorpe Avenue,949-851-4985,Diagnostics & Research,Suite D
t-3,IVRO,428154.0,0,,,-194938,,-194938,,-236367,-236367,-236367,,,,,,0,152518,388885,388885,41429,,-194938,-194938,54856.0,428154.0,54856.0,483010.0,,268571.0,154479.0,59960.0,54856.0,328531.0,428154.0,428154.0,0,273675.0,en-US,US,EQUITY,False,Delayed Quote,-22.301529,0.1241 - 0.1241,0.15972,0.0,0.0,0,0,finmb_327867,Other OTC,InVitro International,USD,8748,4725,0.0619,0.9951769,0.0622 - 0.1994,-0.07529999,-0.3776329,0.0622,0.1994,USD,False,False,us_market,0.1241,1630519605,-0.035620004,0.1241,0.1241,0.1241,1000,PRE,INVITRO INTERNATIONAL,PNK,1564570740,1596034740,1596470400,31.024998,0.004,0,0.03,0.12516694,-0.001066938,-0.008524121,0.118595496,0.005504504,0.046414107,754379,4.136667,15,America/New_York,EDT,-14400000,4,-0.62,,,0.1994,0.0622,0.1252,0.1186,8.75k,4.72k,,,,0.00%,0.00%,,,,,,,,,,,0.00%,,,,,"Sep 29, 2008","Sep 29, 2008",9.35%,8.07%,6.47%,13.73%,696.56k,0.04,-12.90%,56.2k,,65.15k,0.0040,48.80%,332.67k,0.02,,,7.19,0.03,,,Value,92870,Healthcare,"InVitro International develops test kits for non-animal testing in the United States and internationally. Its products include Irritection Assay System, an invitro test, which could be used to detect, rank, and predict the ocular and/or dermal irritation potential of cosmetics, consumer products, pharmaceuticals, and chemical raw materials; and Corrositex, an invitro test that determines chemical corrosivity. The company also provides customized technology services for Irritection Assay System installation and testing process, as well as independent testing laboratory services for irritancy and corrosivity testing requirements. Its products are principally used by the manufacturers of surfactants, petrochemicals, cosmetics, textiles, paper and pulp, pharmaceuticals, films and resins, solvents and cleaners, and other chemical raw materials. The company was founded in 1985 and is headquartered in Placentia, California.",Placentia,949-851-8356,CA,851990400,United States,http://www.invitrointl.com,86400,330 East Orangethorpe Avenue,949-851-4985,Diagnostics & Research,Suite D
